Kristin Hammersbøen Bjørlykke
4PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 10, 2024
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.Hilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton
|Feb 27, 2023
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.Marthe Kirkesaether Brun, Kristin Hammersbøen Bjørlykke, Marte K Viken
|Nov 03, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy.Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter
|Aug 23, 2022
Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia.Kristin H Bjørlykke, Jørgen Jahnsen, Jørn Brynskov
Pageof 1
Frequent Collaborators
3 joint publications
Espen A Haavardsholm
3 joint publications
Guro Løvik Goll
3 joint publications
Silje Watterdal Syversen
2 joint publications
Ingrid Jyssum
2 joint publications
Anne Therese Tveter
2 joint publications
Ingrid Egeland Christensen
2 joint publications
Tore K Kvien
2 joint publications
Sella Aarrestad Provan
1 joint publications
Jørgen Jahnsen
1 joint publications
Hilde S Ørbo
